Skip to main content
logo
Braveheart Bio, Inc. (BRVE)
NASDAQ: BRVE · Real-Time Price · USD
23.60
-0.01 (-0.04%)
Sep 23, 2026, 10:10 AM EDT - Market open

Braveheart Bio Market Cap

Braveheart Bio has a market cap or net worth of $1.51 billion as of September 23, 2026.

Market Cap
1.51B
Enterprise Value
1.39B
1-Year Change
n/a
Ranking
#2282
Category
Small-Cap
Stock Price
$23.60

Chart

Chart

Since the IPO on August 6, 2026, Braveheart Bio's market cap has increased from $1.27B to $1.51B, an increase of 19.08%.

History

DateMarket Cap% Change
Sep 21, 20261.61B-14.32%
Sep 18, 20261.87B5.38%
Sep 17, 20261.78B0.95%
Sep 16, 20261.76B2.77%
Sep 15, 20261.71B-1.15%
Sep 14, 20261.73B1.43%
Sep 11, 20261.71B-2.24%
Sep 10, 20261.75B-5.74%
Sep 9, 20261.86B-1.70%
Sep 8, 20261.89B9.99%
Sep 4, 20261.72B1.79%
Sep 3, 20261.69B-2.52%
Sep 2, 20261.73B2.55%
Sep 1, 20261.69B3.06%
Aug 31, 20261.64B-7.07%
Aug 28, 20261.76B-1.51%
Aug 27, 20261.79B0.36%
Aug 26, 20261.78B0.43%
Aug 25, 20261.77B0.51%
Aug 24, 20261.76B-0.29%
Aug 21, 20261.77B0.58%
Aug 20, 20261.76B-5.35%
Aug 19, 20261.86B8.30%
Aug 18, 20261.72B-3.29%
Aug 17, 20261.77B2.33%
Aug 14, 20261.73B4.08%
Aug 13, 20261.67B-0.69%
Aug 12, 20261.68B4.56%
Aug 11, 20261.60B-9.15%
Aug 10, 20261.77B-8.23%
Aug 7, 20261.93B51.37%
Aug 6, 20261.27B-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Intellia Therapeutics1.71B
Absci1.69B
Immunocore Holdings1.66B
Inhibrx Biosciences1.65B
Taysha Gene Therapies1.64B
AnaptysBio1.63B
Syndax Pharmaceuticals1.61B
Kailera Therapeutics1.55B
Market Cap Rankings